BioLife Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . BioLife Solutions
BLFS Stock  USD 26.77  0.76  2.92%   
BioLife Solutions financial statements provide useful quarterly and yearly information to potential BioLife Solutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioLife Solutions financial statements helps investors assess BioLife Solutions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioLife Solutions' valuation are summarized below:
Gross Profit
54.1 M
Profit Margin
(0.31)
Market Capitalization
1.2 B
Enterprise Value Revenue
8.4846
Revenue
147 M
There are over one hundred nineteen available fundamental signals for BioLife Solutions, which can be analyzed over time and compared to other ratios. All traders should validate BioLife Solutions' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 746 M in 2024. Enterprise Value is likely to gain to about 753.6 M in 2024

BioLife Solutions Total Revenue

150.43 Million

Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 52.9 M or Total Revenue of 150.4 M, as well as many indicators such as Price To Sales Ratio of 4.71, Dividend Yield of 0.0014 or PTB Ratio of 2.0. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

BioLife Solutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets433.3 M412.7 M152 M
Slightly volatile
Other Current Liabilities16.2 M15.4 M5.7 M
Slightly volatile
Total Current Liabilities44.3 M42.2 M13.7 M
Slightly volatile
Cash37.2 M35.4 M20.8 M
Slightly volatile
Non Currrent Assets Other8.4 M8 M3 M
Slightly volatile
Other Assets466.3 M444.1 M122.9 M
Slightly volatile
Cash And Short Term Investments54.3 M51.7 M26 M
Slightly volatile
Common Stock Shares Outstanding45.9 M43.7 M19.9 M
Slightly volatile
Other Current Assets3.6 M6.8 M6.8 M
Pretty Stable
Other Stockholder Equity683.9 M651.3 M238.2 M
Slightly volatile
Total Liabilities78.8 M75.1 M27.4 M
Slightly volatile
Total Current Assets126.6 M120.6 M48.5 M
Slightly volatile
Accounts Payable7.3 M6.9 M3.8 M
Slightly volatile
Non Current Liabilities Total34.5 M32.9 M13.7 M
Slightly volatile
Inventory45.6 M43.5 M12.5 M
Slightly volatile
Net Receivables19.6 M18.7 M8 M
Slightly volatile
Short and Long Term Debt Total44.8 M42.7 M22.5 M
Pretty Stable
Common Stock Total Equity35.1 K38 K28.8 K
Very volatile
Short Term Debt13.8 M13.2 M4.2 M
Slightly volatile
Common Stock36.6 K45 K30.7 K
Very volatile
Current Deferred Revenue694 K661 K406.7 K
Slightly volatile
Property Plant Equipment56.3 M53.6 M16.3 M
Slightly volatile
Other Liabilities2.8 M3 M9.2 M
Slightly volatile
Capital Surpluse365.4 M348 M157 M
Slightly volatile
Deferred Long Term Liabilities47.8 M45.5 M17.1 M
Slightly volatile
Non Current Liabilities Other2 M2.1 M5.2 M
Slightly volatile
Deferred Long Term Asset Charges146.1 K132.1 K121.5 K
Very volatile
Warrants1.1 M1.2 M1.3 M
Slightly volatile
Long Term Debt Total2.3 M2.6 M2.8 M
Slightly volatile
Long Term Investments4.7 M5.6 M3.4 M
Slightly volatile
Short and Long Term Debt7.2 M6.8 M2.6 M
Pretty Stable
Net Invested Capital242.5 M362.8 M123.8 M
Slightly volatile
Net Working Capital65.7 M78.4 M36.2 M
Slightly volatile
Capital Stock37.2 K45 K26.1 K
Slightly volatile
Capital Lease Obligations14.6 M17.5 M6.2 M
Slightly volatile

BioLife Solutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative52.9 M55.7 M16.3 M
Slightly volatile
Total Revenue150.4 M143.3 M47.9 M
Slightly volatile
Other Operating Expenses224.8 M214.1 M63.4 M
Slightly volatile
Cost Of Revenue101.3 M96.5 M29.8 M
Slightly volatile
Total Operating Expenses123.5 M117.6 M33.6 M
Slightly volatile
Research Development19.7 M18.8 M5.8 M
Slightly volatile
Selling And Marketing Expenses23.4 M24.6 M29.3 M
Slightly volatile
Interest Income63.4 K66.7 K81.6 K
Pretty Stable
Preferred Stock And Other Adjustments303.3 K389.9 K272.5 K
Slightly volatile
Reconciled Depreciation7.1 M13.1 M3.7 M
Slightly volatile
Non Recurring643.2 K601.2 K843.2 K
Slightly volatile

BioLife Solutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow20.4 M19.5 M16.7 M
Slightly volatile
End Period Cash Flow37.2 M35.4 M20.3 M
Slightly volatile
Stock Based Compensation18.7 M31.7 M21.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.714.9587131
Slightly volatile
Dividend Yield0.00140.0020.0017
Slightly volatile
Days Sales Outstanding45.1547.530962.2885
Slightly volatile
Average Payables396.1 K630.8 K643 K
Very volatile
Stock Based Compensation To Revenue0.210.2210.1021
Slightly volatile
EV To Sales4.765.0095131
Slightly volatile
Inventory Turnover3.322.22113.898
Slightly volatile
Days Of Inventory On Hand230164165
Slightly volatile
Payables Turnover14.613.90766.1939
Slightly volatile
Sales General And Administrative To Revenue0.370.38890.442
Slightly volatile
Average Inventory2.2 M2.1 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.120.13120.1363
Slightly volatile
Capex To Revenue0.04230.04450.0843
Slightly volatile
Cash Per Share0.641.18240.911
Slightly volatile
Days Payables Outstanding24.9326.244669.7448
Slightly volatile
Intangibles To Total Assets0.30.59580.3951
Slightly volatile
Current Ratio3.32.85944.8128
Pretty Stable
Receivables Turnover8.097.67926.6924
Very volatile
Graham Number17.0616.24926.5801
Slightly volatile
Capex Per Share0.130.1460.1073
Slightly volatile
Average Receivables1.9 M1.8 M1.5 M
Slightly volatile
Revenue Per Share3.443.27711.6094
Slightly volatile
Interest Debt Per Share0.460.68910.6142
Slightly volatile
Debt To Assets0.06520.06860.9287
Slightly volatile
Operating Cycle296212218
Slightly volatile
Days Of Payables Outstanding24.9326.244669.7448
Slightly volatile
Quick Ratio1.741.82913.8608
Very volatile
Cash Ratio0.80.83953.5852
Pretty Stable
Days Of Inventory Outstanding230164165
Slightly volatile
Days Of Sales Outstanding45.1547.530962.2885
Slightly volatile
Fixed Asset Turnover4.884.39255.4881
Very volatile
Debt Ratio0.06520.06860.9287
Slightly volatile
Price Sales Ratio4.714.9587131
Slightly volatile
Asset Turnover0.330.34710.7568
Slightly volatile
Gross Profit Margin0.550.32630.4847
Pretty Stable

BioLife Solutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap746 M710.4 M388.2 M
Slightly volatile
Enterprise Value753.6 M717.7 M379.4 M
Slightly volatile

BioLife Fundamental Market Drivers

Forward Price Earnings250
Cash And Short Term Investments51.7 M

BioLife Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue661 K694 K
Total Revenue143.3 M150.4 M
Cost Of Revenue96.5 M101.3 M
Stock Based Compensation To Revenue 0.22  0.21 
Sales General And Administrative To Revenue 0.39  0.37 
Research And Ddevelopement To Revenue 0.13  0.12 
Capex To Revenue 0.04  0.04 
Revenue Per Share 3.28  3.44 
Ebit Per Revenue(0.49)(0.52)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY